封面
市場調查報告書
商品編碼
1446449

血管影像市場規模、佔有率、趨勢分析報告:按模式、最終用途、地區、細分市場預測,2024-2030 年

Vascular Imaging Market Size, Share & Trends Analysis Report By Modality (CT, MRI, Ultrasound, Nuclear Medicine), By End-Use (Hospitals, Imaging Centers), By Region, And Segment Forecasts, 2024 - 2030

出版日期: | 出版商: Grand View Research | 英文 105 Pages | 商品交期: 2-10個工作天內

價格

血管成像市場成長與趨勢:

Grand View Research, Inc.最新報告顯示,預計2030年全球血管影像市場規模將達85.2億美元,2024年至2030年複合年成長率為4.19%。

心血管疾病盛行率的增加和血管掃描設備技術的不斷進步極大地推動了血管成像市場的發展。此外,增加血管成像設備開發資金籌措預計將進一步提振市場。

包括 3D 視覺化和手持設備在內的超音波技術的最新開拓預計將有助於血管成像市場的成長。 3D 技術取代 2D 技術使得無需移動換能器即可即時擷取 3D 影像。此外,基於平面波成像的向量多普勒技術的發展也越來越受歡迎。這種方法有效地降低了對焦影像所需的影格速率(更少的掃描線)並且可以更快地完成。

由於患者數量的增加,診斷成像中心的激增為製造商引入更高效的成像技術提供了機會。成像技術的持續發展,例如基於 X光的分析和超音波技術,有望擴大血管成像的應用。這些方式在安寧療護和治療照護中都受到高度青睞,以提供優質的醫療保健。

血管成像市場報告亮點

  • 按類型分類,由於不同技術提供的各種好處(例如患者安全和縮短週轉時間),非侵入性細分市場在 2023 年將佔據血管成像市場的最大佔有率。
  • CT 掃描儀具有諸如改進的空間和時間解析度、快速程序以及使用 X 光管從不同角度提供多個影像的能力等優點,預計將擴大這種模式的使用。
  • 由於老年族群心血管疾病的高盛行率以及醫療設施的可用性,2023 年的血管影像市場將由北美主導。
  • 由於低收入和中等收入國家心血管疾病的高發病率,預計亞太血管成像市場在預測期內將呈現良好的成長率。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章血管影像市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 血管影像市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析
    • 價格分析

第4章血管影像市場:模態估計與趨勢分析

  • 2023年及2030年醫療器材市場佔有率
  • 細分儀表板
  • 按模式分類的全球血管成像市場展望
  • 2018年至2030年市場規模、預測與趨勢分析

第5章血管影像市場:最終用途估計與趨勢分析

  • 2023 年及 2030 年最終用途市場佔有率
  • 細分儀表板
  • 按最終用途分類的全球血管成像市場前景
  • 2018年至2030年市場規模、預測與趨勢分析

第6章血管影像市場:區域估計與趨勢分析

  • 2023 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 全球區域市場概況
  • 2018-2030年市場規模及預測趨勢分析:
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商形勢
    • List of key distributors and channel partners
    • Key customers
    • Key company market share analysis, 2023
    • Siemens Healthineers
    • Abbott Laboratories
    • GE Healthcare
    • Koninklijke Philips NV
    • Hitachi Medical Corporation.
    • Samsung Medison Co., Ltd.
    • Shimadzu Corporation
    • Hologic Inc.
    • Carestream Health Inc.
Product Code: GVR-4-68038-020-0

Vascular Imaging Market Growth & Trends:

The global vascular imaging market size is expected to reach USD 8.52 billion by 2030, registering a CAGR of 4.19% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing prevalence of cardiovascular disorders and growing technological advancements in vascular scanning devices are majorly driving the vascular imaging market. In addition, growing funding for developments in vascular imaging devices is further anticipated to fuel the market.

Recent developments in ultrasound technology including 3D visualization and handheld devices are expected to contribute to the vascular imaging market growth. Replacement of 2D technology into 3D has enabled 3D capturing of images without the movement of transducer in real-time. In addition, developments in vector-Doppler technique based on plane-wave imaging is gaining popularity. This method effectively decreases the frame rate (reduces scan-lines) required for focusing an image and more rapidly.

Increasing number of diagnostic imaging centers due to increasing patient pool is an opportunity for the manufacturers to introduce more efficient imaging technologies. Increasing developments in imaging technologies, such as X-ray based analyses and ultrasonography techniques are expected to expand the applications of vascular imaging. These modalities are highly preferred in both palliative and curative care for superior levels of healthcare.

Vascular Imaging Market Report Highlights:

  • By type, non-invasive segment held the largest share in vascular imaging market in 2023 owing to various advantages offered by different techniques, such as patient safety and shorter turnaround time
  • Advantages offered by CT scanners, such as enhanced spatial and temporal resolution, quick technique, and offering of multiple images from different angles with the help of x-ray tube are expected to expand the applications of this modality
  • North America dominated the vascular imaging market in 2023, owing to high prevalence of cardiovascular disorders among geriatric population and well-established healthcare facilities
  • Vascular imaging market in Asia Pacific is expected to witness lucrative growth rate over the forecast period owing to high prevalence of CVDs in lower and middle income economies

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Modality
    • 1.2.2. End Use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Modality outlook
    • 2.2.2. End Use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Vascular Imaging Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Growing prevalence of cancer and cardiac diseases
      • 3.2.1.2. Favorable government initiatives
      • 3.2.1.3. Trends of preventive healthcare and disease screening programs
      • 3.2.1.4. Technological advancements
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of product
      • 3.2.2.2. Increasing use of refurbished products
  • 3.3. Vascular Imaging Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
    • 3.3.3. Pricing Analysis

Chapter 4. Vascular Imaging Market: Modality Estimates & Trend Analysis

  • 4.1. Modality Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Vascular Imaging Market by Modality Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. CT
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. MRI
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Ultrasound
      • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Nuclear Medicine
      • 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Vascular Imaging Market: End-Use Estimates & Trend Analysis

  • 5.1. End-Use Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Vascular Imaging Market by End Use Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Hospitals
      • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
    • 5.4.2. Imaging Centers
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Others
      • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Vascular Imaging Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2023 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.5. North America
    • 6.5.1. U.S.
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. Canada
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Europe
    • 6.6.1. UK
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Germany
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.3. France
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.4. Italy
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework/ reimbursement structure
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.5. Spain
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Regulatory framework/ reimbursement structure
      • 6.6.5.3. Competitive scenario
      • 6.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.6. Norway
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Regulatory framework/ reimbursement structure
      • 6.6.6.3. Competitive scenario
      • 6.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.7. Sweden
      • 6.6.7.1. Key country dynamics
      • 6.6.7.2. Regulatory framework/ reimbursement structure
      • 6.6.7.3. Competitive scenario
      • 6.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.8. Denmark
      • 6.6.8.1. Key country dynamics
      • 6.6.8.2. Regulatory framework/ reimbursement structure
      • 6.6.8.3. Competitive scenario
      • 6.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.2. China
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.3. India
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.4. Australia
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.5. South Korea
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework/ reimbursement structure
      • 6.7.5.3. Competitive scenario
      • 6.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.6. Thailand
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Regulatory framework/ reimbursement structure
      • 6.7.6.3. Competitive scenario
      • 6.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Regulatory framework/ reimbursement structure
      • 6.8.1.3. Competitive scenario
      • 6.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.2. Mexico
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework/ reimbursement structure
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.3. Argentina
      • 6.8.3.1. Key country dynamics
      • 6.8.3.2. Regulatory framework/ reimbursement structure
      • 6.8.3.3. Competitive scenario
      • 6.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Regulatory framework/ reimbursement structure
      • 6.9.1.3. Competitive scenario
      • 6.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Regulatory framework/ reimbursement structure
      • 6.9.2.3. Competitive scenario
      • 6.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.3. UAE
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Regulatory framework/ reimbursement structure
      • 6.9.3.3. Competitive scenario
      • 6.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.4. Kuwait
      • 6.9.4.1. Key country dynamics
      • 6.9.4.2. Regulatory framework/ reimbursement structure
      • 6.9.4.3. Competitive scenario
      • 6.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2023
    • 7.3.4. Siemens Healthineers
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Abbott Laboratories
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. GE Healthcare
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Koninklijke Philips N.V.
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Hitachi Medical Corporation.
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Samsung Medison Co., Ltd.
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Shimadzu Corporation
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. Hologic Inc.
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Product benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. Carestream Health Inc...
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Product benchmarking
      • 7.3.12.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America vascular imaging market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 4 North America vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 5 U.S. vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 6 U.S. vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 7 Canada vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 8 Canada vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Europe vascular imaging market, by region, 2018 - 2030 (USD Million)
  • Table 10 Europe vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 11 Europe vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 12 Germany vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 13 Germany vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 14 UK vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 15 UK vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 16 France vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 17 France vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 18 Italy vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 19 Italy vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Spain vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 21 Spain vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 22 Denmark vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 23 Denmark vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Sweden vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 25 Sweden vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 26 Norway vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 27 Norway vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific vascular imaging market, by region, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 31 China vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 32 China vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 33 Japan vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 34 Japan vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 35 India vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 36 India vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 37 South Korea vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 38 South Korea vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 39 Australia vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 40 Australia vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Thailand vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 42 Thailand vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Latin America vascular imaging market, by region, 2018 - 2030 (USD Million)
  • Table 44 Latin America vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 45 Latin America vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 46 Brazil vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 47 Brazil vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 48 Mexico vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 49 Mexico vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 50 Argentina vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 51 Argentina vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 52 MEA vascular imaging market, by region, 2018 - 2030 (USD Million)
  • Table 53 MEA vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 54 MEA vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 55 South Africa vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 56 South Africa vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 59 UAE vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 60 UAE vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 61 Kuwait vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 62 Kuwait vascular imaging market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Vascular imaging market: market outlook
  • Fig. 14 Vascular imaging competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Vascular imaging market driver impact
  • Fig. 20 Vascular imaging market restraint impact
  • Fig. 21 Vascular imaging market strategic initiatives analysis
  • Fig. 22 Vascular imaging market: Modality movement analysis
  • Fig. 23 vascular imaging market: Modality outlook and key takeaways
  • Fig. 24 CT market estimates and forecast, 2018 - 2030
  • Fig. 25 MRI estimates and forecast, 2018 - 2030
  • Fig. 26 Ultrasound market estimates and forecast, 2018 - 2030
  • Fig. 27 Nuclear Medicine estimates and forecast, 2018 - 2030
  • Fig. 28 Vascular imaging Market: End-use movement Analysis
  • Fig. 29 vascular imaging market: End use movement analysis
  • Fig. 30 vascular imaging market: End use outlook and key takeaways
  • Fig. 31 Hospitals market estimates and forecasts, 2018 - 2030
  • Fig. 32 Imaging Centers market estimates and forecasts,2018 - 2030
  • Fig. 33 Others market estimates and forecasts,2018 - 2030
  • Fig. 34 Global vascular imaging market: Regional movement analysis
  • Fig. 35 Global vascular imaging market: Regional outlook and key takeaways
  • Fig. 36 Global vascular imaging market share and leading players
  • Fig. 37 North America market share and leading players
  • Fig. 38 Europe market share and leading players
  • Fig. 39 Asia Pacific market share and leading players
  • Fig. 40 Latin America market share and leading players
  • Fig. 41 Middle East & Africa market share and leading players
  • Fig. 42 North America, by country
  • Fig. 43 North America market estimates and forecasts, 2018 - 2030
  • Fig. 44 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 45 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 46 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 47 UK market estimates and forecasts, 2018 - 2030
  • Fig. 48 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 49 France market estimates and forecasts, 2018 - 2030
  • Fig. 50 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 51 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 52 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 53 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 54 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 55 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 56 China market estimates and forecasts, 2018 - 2030
  • Fig. 57 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 58 India market estimates and forecasts, 2018 - 2030
  • Fig. 59 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 60 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 61 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 62 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 63 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 64 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 65 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 66 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 67 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 68 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 69 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 70 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 71 Market share of key market players- vascular imaging market